New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase
申请人:PFIZER INC.
公开号:EP0418071A2
公开(公告)日:1991-03-20
Compounds of the formula
the pharmaceutically acceptable salts thereof, wherein Q and R¹ are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
式中的化合物
其药学上可接受的盐,其中 Q 和 R¹ 如下文所定义,以及用于合成此类化合物的新型羧酸和酸卤化物中间体。式 I 的化合物是酰基辅酶 A:胆固醇酰基转移酶(ACAT)的抑制剂,可用作降血脂药和抗动脉粥样硬化药。